Published in J Am Coll Cardiol on November 15, 2001
Antiarrhythmics Versus Implantable Defibrillators (AVID) | NCT00000531
Taxol, a microtubule stabilizer, prevents ischemic ventricular arrhythmias in rats. J Cell Mol Med (2010) 0.83
Microvolt T-wave alternans in end-stage renal disease patients--associations with uremic cardiomyopathy. Clin J Am Soc Nephrol (2010) 0.80
Implantable defibrillators for secondary prevention of sudden cardiac death in cardiac surgery patients with perioperative ventricular arrhythmias. J Am Heart Assoc (2014) 0.80
Prehospital cardiac arrest: a marker for higher mortality in patients with acute myocardial infarction and moderately reduced left ventricular function: results from the MITRA plus registry. Clin Res Cardiol (2008) 0.80
Use of implantable cardioverter defibrillators after out-of-hospital cardiac arrest: a prospective follow-up study. CMAJ (2004) 0.78
Supraventricular tachyarrhythmia as a cause of sudden cardiac arrest. J Interv Card Electrophysiol (2006) 0.77
Effectiveness of implantable cardioverter-defibrillators in survivors of inhospital cardiac arrest. Am Heart J (2015) 0.76
Risk of death and recurrent ventricular arrhythmias in survivors of cardiac arrest concurrent with acute myocardial infarction. Indian Pacing Electrophysiol J (2008) 0.75
Implantable cardioverter-defibrillator therapy in patients with ventricular fibrillation out of hospital cardiac arrest secondary to acute coronary syndrome. J Am Heart Assoc (2015) 0.75
Implantable defibrillators with and without resynchronization for patients with left ventricular dysfunction. Tex Heart Inst J (2005) 0.75
Nearly fatal torsade de pointes with sotalol. Indian Pacing Electrophysiol J (2003) 0.75
Treatable causes of sudden death: not really "treatable" or not really the cause? J Am Coll Cardiol (2001) 1.72
A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med (2002) 16.31
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med (1991) 13.91
Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med (1991) 4.83
Bystander-initiated cardiopulmonary resuscitation in the management of ventricular fibrillation. Ann Intern Med (1979) 4.82
Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA (1993) 4.36
Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med (1992) 3.95
Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med (1999) 3.48
Predicting survival from out-of-hospital cardiac arrest: a graphic model. Ann Emerg Med (1993) 3.39
Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation. JAMA (1999) 3.13
The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. Myocardial Infarction Triage and Intervention Project Investigators. N Engl J Med (1993) 3.12
Breast cancer screening by mammography: utilization and associated factors. Am J Public Health (1989) 3.11
Supraventricular tachycardia. N Engl J Med (1995) 2.85
Use of the automatic external defibrillator in the management of out-of-hospital cardiac arrest. N Engl J Med (1988) 2.76
Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation (1993) 2.71
A residents' training program for the development of smoking intervention skills. Arch Intern Med (1988) 2.61
Treatment of out-of-hospital cardiac arrests with rapid defibrillation by emergency medical technicians. N Engl J Med (1980) 2.60
Development and validation of an ECG algorithm for identifying accessory pathway ablation site in Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol (1998) 2.59
Community-based cardiopulmonary resuscitation: what have we learned? Ann N Y Acad Sci (1982) 2.47
Comparison of in vivo tissue temperature profile and lesion geometry for radiofrequency ablation with a saline-irrigated electrode versus temperature control in a canine thigh muscle preparation. Circulation (1995) 2.45
Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg (1973) 2.44
Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Pacing Clin Electrophysiol (2000) 2.38
Myocardial Infarction Triage and Intervention Project--phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. J Am Coll Cardiol (1990) 2.32
Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med (2000) 2.30
Impact of a guideline-based disease management team on outcomes of hospitalized patients with congestive heart failure. Arch Intern Med (2001) 2.28
Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. J Am Coll Cardiol (1997) 2.27
Assessing clinical skills of residents with standardized patients. Ann Intern Med (1986) 2.26
Intravascular extraction of problematic or infected permanent pacemaker leads: 1994-1996. U.S. Extraction Database, MED Institute. Pacing Clin Electrophysiol (1999) 2.24
When should patients with lethal ventricular arrhythmia resume driving? An analysis of state regulations and physician practices. Ann Intern Med (1991) 2.19
Automatic external defibrillators used by emergency medical technicians. A controlled clinical trial. JAMA (1987) 2.12
Five-years experience with intravascular lead extraction. U.S. Lead Extraction Database. Pacing Clin Electrophysiol (1994) 2.09
Para-Hisian pacing. A new method for differentiating retrograde conduction over an accessory AV pathway from conduction over the AV node. Circulation (1996) 2.08
Role of the tricuspid annulus and the eustachian valve/ridge on atrial flutter. Relevance to catheter ablation of the septal isthmus and a new technique for rapid identification of ablation success. Circulation (1996) 2.04
Factors influencing survival after out-of-hospital cardiac arrest. J Am Coll Cardiol (1986) 1.99
Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol (2003) 1.95
Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia. J Am Coll Cardiol (1998) 1.85
Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation (2001) 1.82
Radiofrequency catheter ablation of right atriofascicular (Mahaim) accessory pathways guided by accessory pathway activation potentials. Circulation (1994) 1.81
Survival of out-of-hospital cardiac arrest with early initiation of cardiopulmonary resuscitation. Am J Emerg Med (1985) 1.77
Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow "focal" ablation. Circulation (2001) 1.73
Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease. J Cardiovasc Electrophysiol (2000) 1.73
Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators. J Am Coll Cardiol (2001) 1.68
Survival of subendocardial Purkinje fibers after extensive myocardial infarction in dogs. Circ Res (1973) 1.65
Weekly and seasonal variation in the incidence of cardiac arrests. Am Heart J (1999) 1.64
Social support, stress, and blood pressure in black adults. Epidemiology (1997) 1.61
Transseptal left heart catheterization for cardiac ablation procedures. J Interv Card Electrophysiol (2001) 1.61
Community cardiopulmonary resuscitation. Annu Rev Med (1980) 1.60
Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities. MITI Investigators. Myocardial Infarction Triage and Intervention. Circulation (1997) 1.59
Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol (2003) 1.59
Circadian variations in the occurrence of cardiac arrests: initial and repeat episodes. Circulation (1998) 1.58
Cardiac arrest treated with a new automatic external defibrillator by out-of-hospital first responders. Am J Cardiol (1986) 1.57
Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol (1990) 1.56
Time course of improvement in ventricular function after ablation of incessant automatic atrial tachycardia. Am Heart J (1991) 1.55
An observational study of attending rounds. J Gen Intern Med (1993) 1.55
Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. J Cardiovasc Electrophysiol (2001) 1.55
Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups. J Am Coll Cardiol (1990) 1.54
Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function. Circulation (1988) 1.52
Characteristics of black patients admitted to coronary care units in metropolitan Seattle: results from the Myocardial Infarction Triage and Intervention Registry (MITI). Am J Cardiol (1991) 1.51
Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. J Am Coll Cardiol (1983) 1.51
Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications. J Am Coll Cardiol (1998) 1.50
Physical activity and primary cardiac arrest. JAMA (1982) 1.48
Catheter entrapment in the mitral valve apparatus during radiofrequency ablation. Pacing Clin Electrophysiol (1994) 1.47
Classification of death in antiarrhythmia trials. J Am Coll Cardiol (1996) 1.44
Coronary spasm with ventricular fibrillation during thyrotoxicosis: response to attaining euthyroid state. Am J Cardiol (1979) 1.44
Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Am Heart J (2002) 1.43
Digitalis glycosides: mechanisms and manifestations of toxicity. Part I. Prog Cardiovasc Dis (1984) 1.41
Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease. N Engl J Med (1976) 1.41
Out-of-hospital transcutaneous pacing by emergency medical technicians in patients with asystolic cardiac arrest. N Engl J Med (1993) 1.40
Spontaneous reversion of ventricular fibrillation. Am Heart J (1988) 1.40
Ventricular defibrillation -- a comparative trial using 175-J and 320-J shocks. N Engl J Med (1982) 1.38
Prinzmetal's angina. Circulation (2000) 1.37
Out-of-hospital cardiac arrest: racial differences in outcome in Seattle. Am J Public Health (1993) 1.37
Transcatheter electrical AV junction ablation: predictors of success. Cleve Clin J Med (1991) 1.36
Amiodarone-associated epididymitis: drug-related epididymitis in the absence of infection. J Urol (1985) 1.33
Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers. Pacing Clin Electrophysiol (2000) 1.32
Potential cost-effectiveness of public access defibrillation in the United States. Circulation (1998) 1.31
Fatty liver: biochemical and clinical considerations. Am J Dig Dis (1975) 1.30
Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation (1998) 1.30
Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads. Circulation (1999) 1.30
Community-based interventions for sudden cardiac death. Impact, limitations, and changes. Circulation (1992) 1.29
Wide complex tachycardia: misdiagnosis and outcome after emergent therapy. Ann Intern Med (1986) 1.28
Rat beta-nerve growth factor sequence and site of synthesis in the adult hippocampus. J Neurosci Res (1988) 1.27
Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study). Am J Cardiol (1989) 1.27
Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol (1983) 1.26
Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities. Circulation (1993) 1.25
Amplitude of ventricular fibrillation waveform and outcome after cardiac arrest. Ann Intern Med (1985) 1.23
Entrainment techniques for mapping atrial and ventricular tachycardias. J Cardiovasc Electrophysiol (1995) 1.21